Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer

NCT01061359 · clinicaltrials.gov ↗

COMPLETED

Status

1981

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: Epirubicin: Observational Study

Sponsor

Pfizer